DAFTAR PUSTAKA

1. Markum HMS. Gangguan Ginjal Akut. Dalam: Sudoyo AW,

Setiyohadi B, Alwi I, Simadibrata M, Setiati S. Buku Ajar Ilmu
Penyakit Dalam, Edisi 5, Jilid I. Jakarta: Interna Publishing. 2009. Hal
1041-9.

2. Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute

kidney injury: a systemic review and meta-analysis. American Journal
of Kidney Diseases. 2011 Sep 30;58(3):356-65.

3. Aydoğdu M, Gürsel G, Sancak B, Yeni S, Sarı G, Taşyürek S, et al.

The use of plasma and urine neutrophil gelatinase associated lipocalin
(NGAL) and Cystatin C in early diagnosis of septic acute kidney
injury in critically ill patients. Disease markers. 2013;34(4):237-46.

4. Soto K, Coelho S, Rodrigues B, Martins H, Frade F, Lopes S, et al.

Cystatin C as a marker of acute kidney injury in the emergency
department. Clinical Journal of the American Society of Nephrology.
2010 Oct 1;5(10):1745-54.

5. Han WK. Biomarkers for early detection of acute kidney injury.

Current Biomarker Findings. 2012 Jan 1;2012(1):77-85.

6. PERNEFRI. 7th Report of Indonesian Renal Registry. 2014. Hal: 8-9.

7. Bagshaw SM, Bellomo R. Cystatin C in acute kidney injury. Current

opinion in critical care. 2010 Dec 1;16(6):533-9.

8. Liangos O, Tighiouart H, Perianayagam MC, Kolyada A, Han WK,

Wald R, et al. Comparative analysis of urinary biomarkers for early
detection of acute kidney injury following cardiopulmonary bypass.
Biomarkers. 2009 Sep 1;14(6):423-31.

9. Parikh CR, Devarajan P. New biomarkers of acute kidney injury.

Critical care medicine. 2008 Apr 1;36(4):S159-65.

10. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the
diagnosis and risk stratification of acute kidney injury: a systematic
review. Kidney international. 2008 May 1;73(9):1008-16.

45
11. Devarajan P. Biomarkers for the early detection of acute kidney
injury. Current opinion in pediatrics. 2011 Apr;23(2):194.

12. Bagshaw SM, Bellomo R. Early diagnosis of acute kidney injury.

Current opinion in critical care. 2007 Dec 1;13(6):638-44.

13. Conti M, Moutereau S, Zater M, Lallali K, Durrbach A, Manivet P, et

al. Urinary cystatin C as a specific marker of tubular dysfunction.
Clinical Chemical Laboratory Medicine. 2006 Mar 1;44(3):288-91.

14. Lagos-Arevalo P, Palijan A, Vertullo L, Devarajan P, Bennett MR,

Sabbisetti V, et al. Cystatin C in acute kidney injury diagnosis: early
biomarker or alternative to serum creatinine?. Pediatric Nephrology.
2015 Apr 1;30(4):665-76.

15. Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J,

Jeevanandam V, et al. Urinary cystatin C as an early biomarker of
acute kidney injury following adult cardiothoracic surgery. Kidney
international. 2008 Oct 2;74(8):1059-69.

16. Park MY, Choi SJ, Kim JK, Hwang SD, Lee YW. Urinary cystatin C
levels as a diagnostic and prognostic biomarker in patients with acute
kidney injury. Nephrology. 2013 Apr 1;18(4):256-62.

17. Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM,

Frampton CM, et al. Urinary cystatin C is diagnostic of acute kidney
injury and sepsis, and predicts mortality in the intensive care unit.
Critical Care. 2010 May 12;14(3):R85.

18. Barash PG, Cullen BF, Stoelting RK. The renal system and anesthesia
for urologic surgery. In: Barash PG, Cullen BF, Stoelting RK, editors.
Clinical Anesthesia 6th ed. Philadelphia: Lippincott Williams &
Wilkins; 2009. Hal: 1346-74.

19. Roesli RM. Diagnosis dan Pengelolaan Gangguan Ginjal Akut. Edisi
kedua. Jakarta: Puspa Swara; 2011.

20. Bagshaw SM, George C, Dinu I, Bellomo R. A multicenter evaluation

of the RIFLE criteria for early acute kidney injury in critical ill
patients. Nephrol dial transplant; 2008, 23:1203-10.

46
21. Hoste EAJ, Clermont G, Kersten A, Venkataraman R, Angus DC,
Bacquer DD, et al. RIFLE criteria for acute kidney injury in critically
ill patients: a cohort analysis. Crit care; 2006; 10:1-10.

22. Ricci Z, Cruz DN, Ronco C. Classification and staging of acute

kidney injury: beyond the RIFLE and AKIN criteria. Nephrology.
Vicenza: Macmillan Publisher Limited; 2011.

23. Li W-x, Chen H-d, Wang X-w, Zhao S, Chen X-k, Zheng Y, et al.
Predictive Value of RIFLE Classification on Prognosis of Critically Ill
Patients with Acute Kidney Injury Treated with Continuous Renal
Replacement Therapy. Chin Med J 2009;122(9):1020-25.

24. Kidney Disease Outcomes Quality Initiative. KDIGO clinical practice

guidelines for acute kidney injury. Kidney Int Suppl. 2012;2(8).

25. Khwaja A. KDIGO clinical practice guidelines for acute kidney

injury. Nephron Clinical Practice. 2012;120(4):c179-84.

26. Zhou J, Liu Y, Tang Y, Liu F, Zhang L, Zeng X, et al. A comparison of

RIFLE, AKIN, KDIGO, and Cys-C criteria for the definition of acute
kidney injury in critically ill patients. International urology and
nephrology. 2016 Jan 1;48(1):125-32.

27. Brady HR, Brenner BM. Acute Renal Failure. In: Dennis LK,
Anthony SF, Dan LL, Eugene B, Stephem LH, Larry J, editors.
Harrison’s Principles of Internal Medicine, 18th ed. New York:
McGraw-Hill;2012. Hal:1644-53.

28. Verdiansah. Pemeriksaan Fungsi Ginjal. CDK-237. 2016;43(2):150.

29. Moore E, Bellomo R, Nichol A. Biomarkers of acute kidney injury in

anesthesia, intensive care and major surgery: from the bench to
clinical research to clinical practice. Minerva Anestesiol,
2010;76(6):425-40.

30. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; workgroup

A. Acute Renal Failure – Definition, Outcome Measures, Animal
Models, Fluid Therapy and Information Technology Needs: The
Second International Consensus Conference of the Acute Dialysis
Quality Initiative (ADQI) Group. Crit care;2004;8(4).

47
31. Geus HR, Betjes MG, Bakker J. Biomarker for the prediction of acute
kidney injury: a narrative review on current status and future
challenges. Clin Kidney J;2012;5:102-8.

32. Devarajan P. Biomarkers for the early detection of acute kidney

injury. Current opinion in pediatrics. 2011 Apr;23(2):194.

33. Mussap M, Plebani M. Biochemistry and clinical role of human

cystatin C. Critical reviews in clinical laboratory sciences. 2004 Jan
1;41(5-6):467-550.

34. Tsiolaki PL, Louros NN, Hamodrakas SJ, Iconomidou VA. Exploring
the ‘aggregation-prone’core of human Cystatin C: A structural study.
Journal of structural biology. 2015 Sep 30;191(3):272-80.

35. Ford SM. Conventional and emerging renal biomarkers. InBiomarkers

in Toxicology 2014 (pp. 261-267).

36. Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KG,

Wickersham N, et al. Urine neutrophil gelatinase-associated lipocalin
moderately predicts acute kidney injury in critically ill adults. Journal
of the American Society of Nephrology. 2009 Aug 1;20(8):1823-32.

37. Devarajan P. Update on mechanisms of ischemic acute kidney injury.

Journal of the American Society of Nephrology. 2006 Jun
1;17(6):1503-20.

38. Matsa R, Ashley E, Sharma V, Walden AP, Keating L. Plasma and

urine neutrophil gelatinase-associated lipocalin in the diagnosis of
new onset acute kidney injury in critically ill patients. Critical Care.
2014 Aug;18(4):R137.

39. Li Q, Fang JY, Wang WP, Liu JH, Wang KK. Cystatin C and serum
creatinine in estimating acute kidney injury of shock patients. World
journal of emergency medicine. 2010;1(3):185.

48